‘Right shoring’ API production in Europe
Pharmaceutical Technology
MARCH 22, 2023
In the 1990s, generic pharmaceutical companies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. Sanofi and Astra Zeneca have also announced plans for new API production plants in Europe.” For example, Roche and GlaxoSmithKline in the UK.
Let's personalize your content